Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

HMN-154

HMN-154 is a benzenesulfonamide anticancer agent. HMN-154 inhibits DNA binding of NF-Y to the human major histocompatibility complex class II human leukocyte antigen DRA Y-box sequence in a dose-dependent manner.

Product Specifications

CAS Number

173528-92-2

Product Name Alternative

HMN-154 | HMN 154 | HMN154

Purity

>98% (HPLC)

Solubility

In Vitro: DMSO : ≥ 15 mg/mL (40.94 mM)

Smiles

C1 (c (cccc1) /C=C/c1ccncc1) NS (=O) (=O) c1ccc (cc1) OC

Molecular Formula

C20H18N2O3S

Molecular Weight

366.44

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Other Product Names

(E) -4- (2- (2- (N- (4-Methoxybenzenesulfonyl) amino) phenyl) ethenyl) pyridine

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

OR4C13, NT (OR4C13, Olfactory receptor 4C13, Olfactory receptor OR11-260)
039386 200 µL

OR4C13, NT (OR4C13, Olfactory receptor 4C13, Olfactory receptor OR11-260)

Sign In for Pricing
View Details
Anti-PIG3 TP53I3 Antibody
A06870-2 100 µL

Anti-PIG3 TP53I3 Antibody

Sign In for Pricing
View Details
Pavunalimab
592102 100 µg

Pavunalimab

Sign In for Pricing
View Details
Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)
MBS1442755-01 0.02 mg (E-Coli)

Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)

Sign In for Pricing
View Details
Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)
MBS1442755-02 0.1 mg (E-Coli)

Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)

Sign In for Pricing
View Details
Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)
MBS1442755-03 0.02 mg (Yeast)

Recombinant Shigella flexneri serotype 5b G/U mismatch-specific DNA glycosylase (mug)

Sign In for Pricing
View Details